Net loss of Piramal Pharma reported to Rs 99.22 crore in the quarter ended September 2025 as against net profit of Rs 22.59 crore during the previous quarter ended September 2024. Sales declined 8.83% to Rs 2043.72 crore in the quarter ended September 2025 as against Rs 2241.75 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2043.722241.75 -9 OPM %7.7615.24 - PBDT156.66312.34 -50 PBT-46.18120.12 PL NP-99.2222.59 PL Powered by Capital Market - Live News

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 5 November 2025.Powered by Capital Market - Live News

The Board of Piramal Pharma at its meeting held on 28 July 2025 has approved the grant of 20,20,507 stock options under ESOP. Powered by Capital Market - Live News

Net Loss of Piramal Pharma reported to Rs 81.70 crore in the quarter ended June 2025 as against net loss of Rs 88.64 crore during the previous quarter ended June 2024. Sales declined 0.89% to Rs 1933.71 crore in the quarter ended June 2025 as against Rs 1951.14 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1933.711951.14 -1 OPM %5.5210.48 - PBDT97.52139.47 -30 PBT-99.76-45.08 -121 NP-81.70-88.64 8 Powered by Capital Market - Live News

Piramal Pharma announced that the Administrative Committee of the Board, at its meeting held today, has approved execution of a sale deed and ancillary definitive agreements with Global Pharma (Buyer) for the sale of decommissioned unit located at A-159, MIDC, Wagle Industrial Estate, Thane West � 400604 for a proposed consideration of approximately Rs. 8.50 core plus applicable taxes. The transaction is expected to conclude within 90 days, subject to fulfilment of conditions as described in the sale deed.The company added, We reiterate that the unit is decommissioned and contributed Nil to the Company`s turnover, income, and net worth in the last financial year. Accordingly, sale will have no impact on Company operations.Powered by Capital Market - Live News